Exercise Approaches and Physical Activity Level in Inactive Adults
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorBiruni University
About this trial
This randomized, controlled, single-blind study aims to compare the effects of different exercise approaches on physical activity level and health-related outcomes in inactive adults. Thirty inactive individuals aged 18-35 years will be randomly assigned to supervised face-to-face group exercise, mobile application-based exercise, or video-based home exercise. Exercise programs will be performed three days per week for eight weeks and will include aerobic, strengthening, and flexibility exercises.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Taking fewer than 5,000 steps per day and classified as physically inactive according to the International Physical Activity Questionnaire-Short Form (<600 MET-min/week)
Residing in Istanbul
Willingness to participate in the study
Disqualifiers
Diagnosis of end-stage congestive heart failure
Presence of malignant or unstable arrhythmia
Lack of adequate infrastructure to participate in technology-based physical activity programs
Presence of mental dysfunction
Trial design
Design model
Parallel
Treatments tested in this trial
Face-to-Face Supervised Exercise
Other interventionParticipants will perform supervised face-to-face group exercise sessions three days per week for eight weeks under the guidance of a physiotherapist. Each session will include aerobic, strengthening, and flexibility exercises.
Mobile App-Based Exercise
DeviceParticipants will perform exercise sessions using the Nike+ Training Club mobile application three days per week for eight weeks. The program will include aerobic, strengthening, and flexibility exercises delivered through asynchronous video content.
Home-Based Video Exercise
Other interventionParticipants will perform video-based home exercise sessions using the "Walk at Home: Leslie" program three days per week for eight weeks. The program will include aerobic, strengthening, and flexibility exercises.
Treatment groups
30 Participants
are divided into 3 treatment groupsGroup A: Face-to-Face Supervised ExerciseExperimental treatment 1 intervention
Group B: Mobile App-Based ExerciseExperimental treatment 1 intervention
Group C: Home-Based Video ExerciseExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Total Physical Activity Level
Physical activity will be assessed using the International Physical Activity Questionnaire-Short Form (IPAQ-SF). Total physical activity will be calculated as metabolic equivalent (MET)-minutes per week based on walking, moderate-intensity, and vigorous-intensity activities performed during the last 7 days. Higher values indicate higher levels of physical activity.
Time frame
From baseline to the end of the intervention at 8 weeksSecondary outcomes
1
Daily Step Count
Daily step count will be measured using a wearable activity tracker. The average number of steps per day will be recorded. Higher values indicate higher levels of physical activity. Unit of Measure is steps per day.
Time frame
From baseline to the end of the intervention at 8 weeks2
Active Time
Active time will be assessed using a wearable activity tracker. The average duration of active movement per day will be recorded. Higher values indicate greater daily physical activity duration. Unit of measure is minutes per day.
Time frame
From baseline to the end of the intervention at 8 weeks3
Energy Expenditure
Daily energy expenditure related to physical activity will be measured using a wearable activity tracker. Higher values indicate greater caloric expenditure through physical activity. Unit of Measure is kilocalories per day.
Time frame
From baseline to the end of the intervention at 8 weeks4
Distance Covered
Distance covered during daily activities will be recorded using a wearable activity tracker. Higher values indicate greater daily movement. Unit of Measure is kilometers per day.
Time frame
From baseline to the end of the intervention at 8 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov